Konferans Bildirisi
BibTex RIS Kaynak Göster

Sleep-related bruxism response to melatonin treatment: three school age children

Yıl 2019, Cilt: 7 Sayı: Ek - IRUPEC 2019 Kongresi Tam Metin Bildirileri, 1 - 4, 10.12.2019

Öz

Bruxism related to sleep involves activation of the chewing muscles and results in tooth clenching, chattering, and grinding. Risk factors related to bruxism in sleep are obstructive sleep apnea, alcohol, caffeine, parasomnias such as sleep-talking and sleepwalking, anxiety, and other psychiatric and neurologic disorders, and some medications. There is still no treatment proven to be effective for the treatment of sleep bruxism. This case presents three school-aged children who presented with bruxism who responded to low-dose melaton

Kaynakça

  • Referanslar 1. American Academy of Sleep Medicine (2005). Diagnostic and Coding Manual 51-55. 2. Guaita M, Hogl B. Current Treatments of Bruxism. Curr Treat Options Neurol. 2016;18(2):10. 3. Lobbezoo F, van der Zaag J, van Selms MK, et al. Principles for the management of bruxism. J Oral Rehabil. 2008;35(7):509-23. 4. Shulman J. Teaching patients how to stop bruxing habits. J Am Dent Assoc. 2001;132(9):1275-7. 5. Jadidi F, Castrillon E, Svensson P. Effect of conditioning electrical stimuli on temporalis electromyographic activity during sleep. J Oral Rehabil. 2008;35(3):171-83. 6. Ommerborn MA, Schneider C, Giraki M, et al. Effects of an occlusal splint compared with cognitive-behavioral treatment on sleep bruxism activity. Eur J Oral Sci. 2007;115(1):7-14. 7. Falisi G, Rastelli C, Panti F, et al. Psychotropic drugs and bruxism. Expert Opin Drug Saf. 2014;13(10):1319-26. 8. Milosevic A, Agrawal N, Redfearn P, et al. The occurrence of toothwear in users of Ecstasy (3,4-methylenedioxymethamphetamine). Community Dent Oral Epidemiol. 1999;27(4):283-7. 9. Uca AU, Uguz F, Kozak HH, et al. Antidepressant-Induced Sleep Bruxism: Prevalence, Incidence, and Related Factors. Clin Neuropharmacol. 2015;38(6):227-30. 10. Lavigne GJ, Huynh N, Kato T, et al. Genesis of sleep bruxism: motor and autonomic-cardiac interactions. 2007;52(4):381-4. 11. Saletu A, Parapatics S, Anderer P, et al. Controlled clinical, polysomnographic and psychometric studies on differences between sleep bruxers and controls and acute effects of clonazepam as compared with placebo. Eur Arch Psychiatry Clin Neurosci. 2010;260(2):163-74. 12. Bostwick JM, Jaffee MS. Buspirone as an antidote to SSRI-induced bruxism in 4 cases. J Clin Psychiatry. 1999;60(12):857-60. 13. Albayrak Y, Ekinci O. Duloxetine-induced nocturnal bruxism resolved by buspirone: case report. Clin Neuropharmacol. 2011;34(4):137-8. 14. Boeve BF, Silber MH, Ferman TJ. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med. 2003;4(4):281-4.
Yıl 2019, Cilt: 7 Sayı: Ek - IRUPEC 2019 Kongresi Tam Metin Bildirileri, 1 - 4, 10.12.2019

Öz

Kaynakça

  • Referanslar 1. American Academy of Sleep Medicine (2005). Diagnostic and Coding Manual 51-55. 2. Guaita M, Hogl B. Current Treatments of Bruxism. Curr Treat Options Neurol. 2016;18(2):10. 3. Lobbezoo F, van der Zaag J, van Selms MK, et al. Principles for the management of bruxism. J Oral Rehabil. 2008;35(7):509-23. 4. Shulman J. Teaching patients how to stop bruxing habits. J Am Dent Assoc. 2001;132(9):1275-7. 5. Jadidi F, Castrillon E, Svensson P. Effect of conditioning electrical stimuli on temporalis electromyographic activity during sleep. J Oral Rehabil. 2008;35(3):171-83. 6. Ommerborn MA, Schneider C, Giraki M, et al. Effects of an occlusal splint compared with cognitive-behavioral treatment on sleep bruxism activity. Eur J Oral Sci. 2007;115(1):7-14. 7. Falisi G, Rastelli C, Panti F, et al. Psychotropic drugs and bruxism. Expert Opin Drug Saf. 2014;13(10):1319-26. 8. Milosevic A, Agrawal N, Redfearn P, et al. The occurrence of toothwear in users of Ecstasy (3,4-methylenedioxymethamphetamine). Community Dent Oral Epidemiol. 1999;27(4):283-7. 9. Uca AU, Uguz F, Kozak HH, et al. Antidepressant-Induced Sleep Bruxism: Prevalence, Incidence, and Related Factors. Clin Neuropharmacol. 2015;38(6):227-30. 10. Lavigne GJ, Huynh N, Kato T, et al. Genesis of sleep bruxism: motor and autonomic-cardiac interactions. 2007;52(4):381-4. 11. Saletu A, Parapatics S, Anderer P, et al. Controlled clinical, polysomnographic and psychometric studies on differences between sleep bruxers and controls and acute effects of clonazepam as compared with placebo. Eur Arch Psychiatry Clin Neurosci. 2010;260(2):163-74. 12. Bostwick JM, Jaffee MS. Buspirone as an antidote to SSRI-induced bruxism in 4 cases. J Clin Psychiatry. 1999;60(12):857-60. 13. Albayrak Y, Ekinci O. Duloxetine-induced nocturnal bruxism resolved by buspirone: case report. Clin Neuropharmacol. 2011;34(4):137-8. 14. Boeve BF, Silber MH, Ferman TJ. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med. 2003;4(4):281-4.
Toplam 1 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Konferans Bildirisi (Tam Metin)
Yazarlar

Semih Erden

Yayımlanma Tarihi 10 Aralık 2019
Kabul Tarihi 16 Ocak 2020
Yayımlandığı Sayı Yıl 2019 Cilt: 7 Sayı: Ek - IRUPEC 2019 Kongresi Tam Metin Bildirileri

Kaynak Göster

Vancouver Erden S. Sleep-related bruxism response to melatonin treatment: three school age children. pediatr pract res. 2019;7(Ek):1-4.